Latest / Philadelphia News Today | 2 Min News | The Daily News Now!
FDA Approves First Alzheimer’s Drug in Years | Philadelphia News
FDA just approved Leqembi, the first drug in years to slow early-stage Alzheimer’s by clearing brain amyloid plaques—offering hope but with caution, as it requires IV infusions every two weeks and carries risks like brain swelling or bleeding. While not a cure, this breakthrough marks a pivotal moment in Alzheimer’s treatment, urging doctors to screen for genetic markers before prescribing. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.